Cytonus Therapeutics

Developer of adoptive cellular therapy for cancer treatment

placeColumbus, Ohio, United States calendar_todayFounded 2018 groups10 employees language cytonus.com

Registered entities

Innovation

7 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 73 times.

YearFilings
20211
20222
20233
20246
20255
20263

Social engagement

Social engagement: 1.7K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Partners Investment.

Investor typeCountShare
Venture capital114%
Private equity229%
Other / undisclosed457%

Recent activity

24 Jun 2026
Event
BIO2026
Coming soon